ICON Report Highlights Need for Resources to Meet New Safety Regulations

Wednesday, June 24, 2009 08:59 AM

A new report released by ICON last week says new safety regulations have created a greater demand for resources to ensure those regulations are met.

The report is based on a survey, commissioned by ICON and market intelligence firm IMS Health, of 140 industry safety specialists within large and mid-size pharmaceutical companies. 

According to "Safety First: The Impact of New Regulations on Clinical Development," 77% of respondents said new safety regulations have had a considerable impact on the drug development industry, and 53% of those surveyed highlighted their regulatory departments in particular as requiring resources within the next six months.

Respondents to the survey said they anticipate phase IV trial activity will grow in the next five years, and 58% said that safety registries increasingly will be used to monitor drug safety at every stage of the clinical trial process.

"The move toward greater transparency around drug safety remains a regulatory and political priority worldwide," said Nigel Burrows, senior principal, management consulting, IMS. "The pharmaceutical industry has and continues to respond to this challenge, both in drug clinical development and commercialization. These efforts have the potential to go beyond simply satisfying regulatory requirements, leading to more clinically effective and commercially viable advances that improve outcomes and set new standards of care."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs